{"disease":{"id":"gad-65-antibody-associated-epilepsy","name":"gad 65 antibody associated epilepsy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05361447","title":"Diazepam Trial in GAD65 Associated Epilepsy","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}